Zobrazeno 1 - 10 of 18 pro vyhledávání: '"OuYang HY"'
1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
Akademický článek
[Research progress in targeting GPRC5D for the treatment of multiple myeloma].
Autor: An JY; National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Shanghai 200025, China., Pan MM; National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Shanghai 200025, China., Ouyang HY; National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Shanghai 200025, China., Mi JQ; National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Shanghai 200025, China.
Publikováno v: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2024 Sep 14; Vol. 45 (9), pp. 883-888.
Zobrazit plný text záznamu
4
Akademický článek
The Association of Morphological Differences of Middle Cerebral Artery Bifurcation and Aneurysm Formation: A Systematic Review and Meta-Analysis.
Autor: Tan J; Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China., Zhu H; Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China., Huang J; Department of Radiology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China., Ouyang HY; Huankui Academy, Nanchang University, Nanchang, Jiangxi, China., Pan X; Huankui Academy, Nanchang University, Nanchang, Jiangxi, China., Zhao Y; Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China. Electronic address: zyp19850922@126.com., Li M; Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China. Electronic address: limeihua2000@sina.com.
Publikováno v: World neurosurgery [World Neurosurg] 2022 Nov; Vol. 167, pp. 17-27. Date of Electronic Publication: 2022 Aug 24.
Zobrazit plný text záznamu
5
Akademický článek
Use of Thidiazuron for High-Frequency Callus Induction and Organogenesis of Wild Strawberry ( Fragaria vesca ).
Autor: Chung HH; Department of Horticulture, National Ilan University, Yilan 26047, Taiwan., Ouyang HY; Department of Horticulture, National Ilan University, Yilan 26047, Taiwan.
Publikováno v: Plants (Basel, Switzerland) [Plants (Basel)] 2020 Dec 30; Vol. 10 (1). Date of Electronic Publication: 2020 Dec 30.
Zobrazit plný text záznamu
6
Akademický článek
Immunosuppressive Immature Myeloid Cell Generation Is Controlled by Glutamine Metabolism in Human Cancer.
Autor: Wu WC; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, P.R. China., Sun HW; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, P.R. China., Chen J; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, P.R. China.; MOE Key Laboratory of Gene Function and Regulation, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, P.R. China., OuYang HY; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, P.R. China., Yu XJ; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, P.R. China., Chen HT; First Affiliated Hospital, Sun Yat-sen University, Guangzhou, P.R. China., Shuang ZY; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, P.R. China., Shi M; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, P.R. China., Wang Z; First Affiliated Hospital, Sun Yat-sen University, Guangzhou, P.R. China., Zheng L; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, P.R. China. zhenglm@mail.sysu.edu.cn.; MOE Key Laboratory of Gene Function and Regulation, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, P.R. China.
Publikováno v: Cancer immunology research [Cancer Immunol Res] 2019 Oct; Vol. 7 (10), pp. 1605-1618. Date of Electronic Publication: 2019 Aug 06.
Zobrazit plný text záznamu
7
Akademický článek
Genome-wide CRISPR knockout screens identify NCAPG as an essential oncogene for hepatocellular carcinoma tumor growth.
Autor: Wang Y; Division of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore., Gao B; Division of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore., Tan PY; Division of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore., Handoko YA; Division of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore., Sekar K; Division of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore., Deivasigamani A; Division of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore., Seshachalam VP; Division of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore., OuYang HY; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China., Shi M; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China., Xie C; Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China., Goh BKP; Department of Hepato-Pancreato-Biliary and Transplant Surgery, Singapore General Hospital, Singapore., Ooi LL; Department of Hepato-Pancreato-Biliary and Transplant Surgery, Singapore General Hospital, Singapore.; Division of Surgical Oncology, National Cancer Centre Singapore, Singapore., Man Hui K; Division of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore.; Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore (NUS), Singapore.; Institute of Molecular and Cell Biology, Agency for Science, Technology, and Research (A*STAR), Singapore.; Duke-NUS Medical School, Singapore.
Publikováno v: FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2019 Aug; Vol. 33 (8), pp. 8759-8770. Date of Electronic Publication: 2019 Apr 25.
Zobrazit plný text záznamu
8
Akademický článek
Aberrant MCT4 and GLUT1 expression is correlated with early recurrence and poor prognosis of hepatocellular carcinoma after hepatectomy.
Autor: Chen HL; Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, Guangzhou, 510060, Guangdong, China.; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, Guangdong, China.; Sate Key Laboratory of Oncology in South Guangzhou, 510060, Guangdong, China., OuYang HY; GI Cell Biology Research Laboratory, Children's Hospital Boston and Harvard Medical School, Boston, MA, USA., Le Y; Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, Guangzhou, 510060, Guangdong, China.; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, Guangdong, China.; Sate Key Laboratory of Oncology in South Guangzhou, 510060, Guangdong, China., Jiang P; Fourth Internal Medicine, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, 510095, Guangdong, China., Tang H; Department of Hepatobiliary Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, 510095, Guangdong, China., Yu ZS; Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, Guangzhou, 510060, Guangdong, China.; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, Guangdong, China.; Sate Key Laboratory of Oncology in South Guangzhou, 510060, Guangdong, China., He MK; Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, Guangzhou, 510060, Guangdong, China.; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, Guangdong, China.; Sate Key Laboratory of Oncology in South Guangzhou, 510060, Guangdong, China., Tang YQ; Department of Hepatobiliary Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, 510095, Guangdong, China., Shi M; Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, Guangzhou, 510060, Guangdong, China.; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, Guangdong, China.; Sate Key Laboratory of Oncology in South Guangzhou, 510060, Guangdong, China.
Publikováno v: Cancer medicine [Cancer Med] 2018 Nov; Vol. 7 (11), pp. 5339-5350. Date of Electronic Publication: 2018 Oct 10.
Zobrazit plný text záznamu
9
Akademický článek
Matrix metalloproteinase 12 expression is associated with tumor FOXP3 + regulatory T cell infiltration and poor prognosis in hepatocellular carcinoma.
Autor: He MK; Department of Hepatobiliary Oncology, Cancer Center, Sun Yat-Sen University, Guangzhou, Guangdong 510060, P.R. China.; Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-Sen University, P.R. China., Le Y; Department of Hepatobiliary Oncology, Cancer Center, Sun Yat-Sen University, Guangzhou, Guangdong 510060, P.R. China.; Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-Sen University, P.R. China., Zhang YF; Department of Hepatobiliary Oncology, Cancer Center, Sun Yat-Sen University, Guangzhou, Guangdong 510060, P.R. China.; Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-Sen University, P.R. China., Ouyang HY; Department of Hepatobiliary Oncology, Cancer Center, Sun Yat-Sen University, Guangzhou, Guangdong 510060, P.R. China.; Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-Sen University, P.R. China.; State Key Laboratory of Oncology in South China, Guangzhou, Guangdong 510060, P.R. China., Jian PE; Department of Hepatobiliary Oncology, Cancer Center, Sun Yat-Sen University, Guangzhou, Guangdong 510060, P.R. China.; Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-Sen University, P.R. China., Yu ZS; Department of Hepatobiliary Oncology, Cancer Center, Sun Yat-Sen University, Guangzhou, Guangdong 510060, P.R. China.; Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-Sen University, P.R. China., Wang LJ; Department of Hepatobiliary Oncology, Cancer Center, Sun Yat-Sen University, Guangzhou, Guangdong 510060, P.R. China.; Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-Sen University, P.R. China., Shi M; Department of Hepatobiliary Oncology, Cancer Center, Sun Yat-Sen University, Guangzhou, Guangdong 510060, P.R. China.; Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-Sen University, P.R. China.; State Key Laboratory of Oncology in South China, Guangzhou, Guangdong 510060, P.R. China.
Publikováno v: Oncology letters [Oncol Lett] 2018 Jul; Vol. 16 (1), pp. 475-482. Date of Electronic Publication: 2018 May 04.
Zobrazit plný text záznamu
10
Akademický článek
Prognostic significance of sodium-potassium ATPase regulator, FXYD3, in human hepatocellular carcinoma.
Autor: Wang LJ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P.R. China.; Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P.R. China., Li QJ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P.R. China.; Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P.R. China., Le Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P.R. China.; Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P.R. China., Ouyang HY; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P.R. China.; Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P.R. China., He MK; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P.R. China.; Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P.R. China., Yu ZS; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P.R. China.; Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P.R. China., Zhang YF; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P.R. China.; Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P.R. China., Shi M; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P.R. China.; Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P.R. China.
Publikováno v: Oncology letters [Oncol Lett] 2018 Mar; Vol. 15 (3), pp. 3024-3030. Date of Electronic Publication: 2017 Dec 21.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje